These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 767285)

  • 1. Immunologic protection of rabbit corneal allografts: prolonged survival of allografts pretreated with homologous antibody against transplantation antigens.
    Chandler JW
    Invest Ophthalmol; 1976 Mar; 15(3):213-6. PubMed ID: 767285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic protection of rabbit corneal allografts with heterologous 'blocking' antibody. Immunologic protection of corneal allografts.
    Binder PS; Gebhardt BM; Chandler JW; Kaufman HE
    Mod Probl Ophthalmol; 1976; 16():175-80. PubMed ID: 765782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic protection of rabbit corneal allografts: preparation and in vitro testing of heterologous "blocking" antibody.
    Chandler JW; Gebhardt BM; Kaufman HE
    Invest Ophthalmol; 1973 Sep; 12(9):646-53. PubMed ID: 4582461
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged survival of a rabbit skin allograft following corneal transplantation from the same donor.
    Engelstein JM; Herberman RB; Tissot RG; Cohen C; Waltman SR
    Ann Ophthalmol; 1973 Dec; 5(12):1305-12. PubMed ID: 4588741
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological protection of rabbit corneal allografts. Survival of corneas pretreated with succinylated antilymphocyte globulin.
    Chandler JW; Gebbhardt BM; Sugar J; Kaufman HE
    Transplantation; 1974 Jan; 17(1):146-8. PubMed ID: 4588153
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro demonstration of cytotoxic antibodies and their possible role in corneal graft rejections.
    Binder PS; Chandler JW; Kaufman HE
    Invest Ophthalmol; 1976 Jun; 15(6):481-4. PubMed ID: 776892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic protection of rabbit corneal allografts with heterologous blocking antibody.
    Binder PS; Gebhardt BM; Chandler JW; Kaufman HE
    Am J Ophthalmol; 1975 Jun; 79(6):949-54. PubMed ID: 166562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the ocular immune response. I. Use of antilymphocytic serum to prevent immune rejection of penetrating corneal homografts.
    Waltman SR; Faulkner HW; Burde RM
    Invest Ophthalmol; 1969 Apr; 8(2):196-200. PubMed ID: 4887870
    [No Abstract]   [Full Text] [Related]  

  • 13. Conditions affecting enhanced corneal allograft survival by oral immunization.
    Ma D; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1835-46. PubMed ID: 9727406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tissue dose and site of grafting on immunity to corneal allografts.
    Gebhardt BM
    Invest Ophthalmol Vis Sci; 1988 Nov; 29(11):1663-70. PubMed ID: 3053528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of histocompatibility upon the corneal immune reaction after interlamellar allotransplantation in rabbits.
    Ehlers N; Ahrons S
    Tissue Antigens; 1971; 1(1):23-31. PubMed ID: 4949392
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged renal allograft survival associated with antigen pretreatment.
    Wilson RE; Rippen A; Hayes CR; Dagher RK; Busch GJ
    Transplant Proc; 1969 Mar; 1(1):290-2. PubMed ID: 4944229
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats.
    Slegers TP; Torres PF; Broersma L; van Rooijen N; van Rij G; van der Gaag R
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2239-47. PubMed ID: 10892868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
    Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV
    Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of donor storage time on corneal allograft survival.
    Simon M; Fellner P; El-Shabrawi Y; Ardjomand N
    Ophthalmology; 2004 Aug; 111(8):1534-8. PubMed ID: 15288984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.